Oral Oncology

Papers
(The H4-Index of Oral Oncology is 27. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
Management and outcome of middle ear adenomatous neuroendocrine tumours: A systematic review274
Surgical treatment of benign parotid gland tumors: From functional surgery to personalized surgery93
Comment on, “Development of a prediction model for tube feeding dependence in HPV-associated oropharyngeal cancer patients undergoing chemoradiotherapy”78
Sarcomatoid salivary duct carcinoma of Parotid: A case report and Review of the Literature64
Evolution of testing for the diagnosis of human papillomavirus (HPV) status in head and neck squamous cell carcinoma: Where from and where to?59
Radiation-induced osteosarcoma in the head and neck region: Case report and literature review54
A rare case of recurrent calcifying epithelial odontogenic tumor in an adolescent patient: Case report and review of literature53
A single-cell sequencing-based analysis of a 13-year-old with maxillary sinus NUT carcinoma47
Effective, efficient palliative radiotherapy for advanced head and neck cancer: Real world data using 25 Gy in 5 fractions42
Oncologic significance of the lateral margin in buccal cancer41
Dysphagia in head and neck cancer patients with evidence of esophageal dysmotility on manometry39
Addressing knowledge gaps in HPV-related oropharyngeal cancer prevention: A call for action38
Alcohol attributed Oral Cancer and Oral microbiome: Emerging yet neglected research domain38
Enhanced recovery after surgery (ERAS) in head and neck oncologic surgery: Impact on return to intended oncologic therapy (RIOT) and survival37
Does lymphovascular invasion predict survival in oral cancer? A population-based analysis36
Implication of dental insurance status on patterns of pre-radiation dental extraction and risk of osteoradionecrosis of the jaw in head-and-neck cancer patients33
The efficacy of adjuvant chemotherapy in patients with different midpoint-radiotherapy Epstein-Barr virus DNA plasma loads32
Prognostic nomograms for nasopharyngeal carcinoma with nodal features and potential indication for N staging system: Validation and comparison of seven N stage schemes32
Comment on “Extensive necrosis of the tongue as a very early adverse event of head and neck radiotherapy”31
Does identification of determinants that delay adjuvant treatment and discussing the benefits of adjuvant treatment with patients create an impact?29
Undifferentiated small round cell sarcoma of the parapharyngeal space in a 4.5-year-old patient:A rare case report29
Omitting elective neck dissection in cT1/2N0 oral squamous cell carcinoma with sentinel lymph node metastasis: A prospective study29
Prospective comparison of acute severe toxicities between smokers and non-smokers during radiotherapy for head and neck cancers29
Pathologic responses and clinical outcomes with neoadjuvant doublet chemotherapy for newly diagnosed, surgically-resectable p16-positive oropharyngeal cancer29
Evaluation of the matrix metalloproteinase 9 (MMP9) inhibitor Andecaliximab as an Anti-invasive therapeutic in Head and neck squamous cell carcinoma28
The spiral ladder technique of facial nerve trunk identification during parotidectomy: A convenient roadmap for the beginners28
Locally advanced lymphoepithelial carcinoma of the larynx/hypopharynx: A case report28
Phase I / II trial of metformin as a chemo-radiosensitizer in a head and neck cancer patient population27
Personalized mRNA cancer vaccines with immune checkpoint inhibitors: A promising therapeutic approach in oral cancer patients27
0.12580895423889